Stay updated on AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating that access to the page is blocked. The layout mirrors a standard error page with a 403 message and site header/footer.SummaryDifference21%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a small editorial or system-level update.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the Study Details page. This indicates a minor update or patch to the page's content/structure rather than a substantive alteration to study information.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, representing a new build/patch level of the page.SummaryDifference0.0%

Stay in the know with updates to AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.